ArticlePloS one2015

Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.

Shohei Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.